Home › Funds › TCG Crossover Management, LLC › ZLAB
TCG Crossover Management, LLC position in ZLAB
ZAI LAB LTD · Health Care
TCG Crossover Management, LLC reported holding 6,229,081 shares of ZLAB (ZAI LAB LTD) in its Q3 2026 13F filing — a position valued at US$164.1M, representing 4.64% of its reported portfolio and ranking #6 among its reported holdings. TCG Crossover Management, LLC has disclosed ZLAB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How TCG Crossover Management, LLC's ZLAB position evolved
TCG Crossover Management, LLC first disclosed a stake in ZLAB in Q2 2026 at 6,137,627 shares (US$116.6M). The position peaked in Q3 2026 at 6,229,081 shares, worth US$164.1M. Across 2 filings, TCG Crossover Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 6,229,081 shares valued at US$164.1M — an increase of 91,454 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 6.14M | $116.61M | New |
| Q3 2026 | 6.23M | $164.07M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZLAB and 13F data
ZLAB (ZAI LAB LTD) is a Health Care company. 17 other funds we track also report a position in ZLAB — the largest reported positions include RTW INVESTMENTS, LP (US$272.6M), Woodline Partners LP (US$139.6M), RA CAPITAL MANAGEMENT, L.P. (US$109.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZLAB
- RTW INVESTMENTS, LP 10.35M sh · $272.64M · Q3 2026
- Woodline Partners LP 5.30M sh · $139.58M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 5.74M sh · $109.13M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.90M sh · $36.14M · Q2 2026
- Spruce Street Capital LP 1.04M sh · $27.45M · Q3 2026
- Rock Springs Capital Management LP 791.31K sh · $20.84M · Q3 2026
- Patient Square Capital LP 591.51K sh · $15.58M · Q3 2026
- C WorldWide Group Holding A/S 510.00K sh · $13.43M · Q3 2026
- B Group, Inc. 450.65K sh · $11.87M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 362.67K sh · $9.55M · Q3 2026
More on TCG Crossover Management, LLC
FAQ
How long has TCG Crossover Management, LLC held ZLAB?
TCG Crossover Management, LLC has disclosed ZLAB holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is TCG Crossover Management, LLC's current position in ZLAB?
As of Q3 2026, TCG Crossover Management, LLC holds 6.23M shares of ZLAB (ZAI LAB LTD), valued at $164.07M, representing 4.64% of its reported portfolio and ranking #6.
Has TCG Crossover Management, LLC been buying or selling ZLAB?
In the latest 13F filing (Q3 2026), TCG Crossover Management, LLC increased its position in ZLAB. The position peaked in Q3 2026 at 6.23M shares.
Which other funds hold ZLAB?
Other major institutional holders of ZLAB include RTW INVESTMENTS, LP, Woodline Partners LP, RA CAPITAL MANAGEMENT, L.P., among 17 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.